Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Agewall

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
American Journal of Hypertension|March 21, 1998
Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention studyB Fagerberg, J Wikstrand, G Berglund, et al.
American Journal of Hypertension|April 1, 1995
Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study GroupS Agewall, J Wikstrand, S Ljungman, et al.
Thrombosis and Haemostasis|November 1, 2000
Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old menS Agewall, L Bokemark, J Wikstrand, et al.
Journal of Internal Medicine|January 1, 1995
The cost-effectiveness of a cardiovascular multiple-risk-factor intervention programme in treated hypertensive menM Johannesson, S Agewall, M Hartford, et al.
Stroke|February 5, 1999
Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertensionB Fagerberg, J Gnarpe, H Gnarpe, et al.
European Journal of Clinical Investigation|November 1, 1996
Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycansB Fagerberg, O Wiklund, S Agewall, et al.
Clinical Laboratory|October 28, 2011
The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarctionS Ghanavatian, R A Stein, D Atar, et al.
Scandinavian Journal of Rheumatology|December 14, 2011
Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patientsG Hjeltnes, I Hollan, Ø Førre, et al.
Journal of Internal Medicine|April 12, 2001
Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-upS Agewall, B Fagerberg, G Berglund, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|August 1, 1994
Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) GroupM Suurküla, S Agewall, B Fagerberg, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Hypertension|March 21, 1998
Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention studyB Fagerberg, J Wikstrand, G Berglund, et al.
American Journal of Hypertension|April 1, 1995
Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study GroupS Agewall, J Wikstrand, S Ljungman, et al.
Thrombosis and Haemostasis|November 1, 2000
Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old menS Agewall, L Bokemark, J Wikstrand, et al.
Journal of Internal Medicine|January 1, 1995
The cost-effectiveness of a cardiovascular multiple-risk-factor intervention programme in treated hypertensive menM Johannesson, S Agewall, M Hartford, et al.
Stroke|February 5, 1999
Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertensionB Fagerberg, J Gnarpe, H Gnarpe, et al.
European Journal of Clinical Investigation|November 1, 1996
Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycansB Fagerberg, O Wiklund, S Agewall, et al.
Clinical Laboratory|October 28, 2011
The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarctionS Ghanavatian, R A Stein, D Atar, et al.
Scandinavian Journal of Rheumatology|December 14, 2011
Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patientsG Hjeltnes, I Hollan, Ø Førre, et al.
Journal of Internal Medicine|April 12, 2001
Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-upS Agewall, B Fagerberg, G Berglund, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|August 1, 1994
Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) GroupM Suurküla, S Agewall, B Fagerberg, et al.
Pageof 8